Genetic Genealogist on 23andMe's ancestry testing

Genetic genealogist Blaine Bettinger explores the results of his ancestry testing from 23andMe, and compares it to previous results from a much lower-resolution test.

The main message: the hundreds of thousands of genetic markers used by 23andMe (and other personal genomics companies, e.g. deCODEme) to infer genetic ancestry  provide a much more detailed and accurate picture of the geographical origins of your genome.

No surprises here. The power of the type of genome-wide genotype data generated by 23andMe for ancestry prediction has been compellingly illustrated by a series of recent studies comparing genetic clustering with geographical origins. Here's one example comparing a map of northern Finland with the genetic clustering of its population, based on the same type of data:


The geographical and genetic maps have the same colour scheme, so you can see immediately how astonishingly well geographical origins can be inferred from this type of genomic information. Similar maps have been generated for other isolated populations (e.g. Sardinia), and for fine-scale structure within broader regions such as Europe and East Asia.

None of the personal genomics companies has yet harnessed the full power of ancestry prediction algorithms, although 23andMe's advanced global similarity tool appears to be the best attempt currently on the market (screen shot for their European substructure view below the fold.)

Blaine is clear that his interest in the results from 23andMe was primarily due to ancestry testing rather than disease risk prediction (he discusses his other results here). He's not alone; as best I can tell, a substantial fraction of the personal genomics market is currently driven by  a fascination with genetic ancestry. That's a huge market: as Blaine noted in another recent post, one genetic genealogy company alone has sold over half a million testing kits.

Subscribe to Genetic Future.

23andMe's advanced global similarity tool, Europe view:

More like this

Yesterday I discussed the decision of personal genomics company 23andMe to slash its price for a genome scan by 60%, to under $400. In the comments to that post, industry observer David Hamilton pointed me to an article he's written for BNET on the implications of 23andMe's price plunge, which (…
Steve Murphy is up in arms about a recent email from 23andMe to its customers advertising the use of genetic variants on its V2 chip to predict individual risk of statin-induced myopathy and breast cancer. Of course, Steve does have a strong financial interest in 23andMe staying as far away as…
Peter Aldhous has a great piece of detective work in New Scientist, which has revealed a bizarre and sporadic glitch in the online software provided by personal genomics company deCODEme to allow customers to view their genetic data. The glitch appears to be restricted to the display of data from…
Update 30/11/10: 23andMe has extended their 80% discount until Christmas, without a need for a discount code. Personal genomics company 23andMe has made some fairly major announcements this week: a brand new chip, a new product strategy (including a monthly subscription fee), and yet another…